Serum lipids and estrogen receptor gene polymorphisms in male-to-female transsexuals: Effects of estrogen treatment

European Journal of Internal Medicine

Volumn 15, Issue 4, 2004, Pages 231-237

  Sosa, Manuel ^a,b   Jódar, Esteban ^c   Arbelo, Elena ^a   Domínguez, Casimira ^d   Saavedra, Pedro ^a   Torres, Armando ^e   Salido, Eduardo ^e   Liminana J M ^a   Gómez De Tejada, María Jesús ^f   Hernández, Diego ^b  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b Insular Hospital   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e UNIVERSIDAD DE LA LAGUNA   (Spain)

^f UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Estrogen receptor gene polymorphism; Estrogens; Lipids; Transsexuals

Indexed keywords

ANTIANDROGEN; APOLIPOPROTEIN B; BIOCHEMICAL MARKER; CONJUGATED ESTROGEN; CYPROTERONE ACETATE; DIANE; ESTRADIOL; ESTRADIOL VALERATE PLUS NORETHISTERONE; ESTROGEN; ESTROGEN RECEPTOR; ETHINYLESTRADIOL PLUS LEVONORGESTREL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESTRANOL PLUS NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; TESTOSTERONE;

ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA POLYMORPHISM; ESTRADIOL BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MALE; PREVALENCE; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TRANSSEXUALISM;

EID: 3543078149     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2004.04.009     Document Type: Article

References (26)

1. Sullivan J.M., Vander Zwaag R., Lemp G.F., Hughes J.P., Maddock V., Kroetz F.W., et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann. Intern. Med. 108:1988;358-363
2. Shlipak M.G., et al. Heart and Estrogen/Progestin Replacement Study Investigators Lipid changes on hormone therapy and coronary heart disease events in the heart and estrogen/progestin replacement study (HERS). Am. Heart J. 146:2003;870-875
3. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 288:2002;321-323
4. Manson J.E., Hsia J., Johnson K.C., Rossouw J.E., Assaf A.R., Lasser N.L., et al. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349:2003;523-534
5. Herrington D.M., Howard T.D., Hawwkins G.A., Reboussin D.M., Xu J., Zheng S.L., et al. Estrogen receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary artery disease. N. Engl. J. Med. 346:2002;967-974
6. Vatalas I.A., Dionyssious-Asteriou A. Adrenal C19 steroids and serum lipoprotein levels in healthy men. Nutr. Metab. Cardiovasc. Dis. 11:2001;388-393
7. Morrison J.A., Sprecher D.L., Biro F.M., Apperson-Hausen C., Dipaola L.M. Serum testosterone associates with lower high-density lipoprotein cholesterol in black and whites males, 10 to 15 years of age, through lowered apolipoprotein AI and AII concentrations. Metabolism. 51:2002;432-437
8. Berg G., Schreier L., Geloso G., Otero P., Nagelberg A., Levalle O. Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men. Horm. Metab. Res. 34:2002;87-92
9. Grupo de trabajo sobre protocolos y práctica clínica SEIOMM Datos básicos en osteoporosis. Rev. Esp. Enferm. Metab. Óseas. 9:2000;84-85
10. Burstein M., Samaille J. Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérum. Clin. Chim. Acta. 5:1960;609
11. Friedewald W.T., Levy R.I., Fredickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502
12. Martin K.A., Douglas P.S. Rose BD Risks and side effects associated with oral contraceptives. 2003;. Up to date, Wellesley, MA
13. Lobo R.A., Skinner J.B., Lippman J.S., Cirillo S.J. Plasma lipids and desogestrel and ethynyl estradiol: a meta-analysis. Fertil. Steril. 65:1996;1100-1109
14. Binder E.F., Williams D.B., Schechtman K.B., Jeffe D.B., Kohrt W.M. Effects of hormone replacement therapy on serum lipids in elderly women. A randomized, placebo-controlled trial. Ann. Intern. Med. 134:2001;754-760
15. Laton B., Rose S., McLeod D., Dowell A. Changes in the use of hormonal replacement therapy after the report from Women's Health Initiative: a cross sectional survey of users. BMJ. 327:2003;845-846
16. Sudhir K., Chou T.M., Chatterjee K., Smith E.P., Williams T.C., Kane J.P., et al. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation. 96:1997;3774-3777
17. Hodgin J.B., Krege J.H., Reddick R.L., Korach K.S., Smithies O., Maeda N. Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/-?? mice. J. Clin. Invest. 107:2001;333-340
18. Novoa F.J., Boronat M., Carrillo A., Tapia M., Diaz-Cremades J., Chirino R. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia. Horm. Res. 57:2002;187-191
19. Inukai T., Takanashi K., Takebayashi K., Tayama K., Aso Y., Takiguchi Y., et al. Estrogen markedly increases LDL-receptor activity in hypercholesterolemic patients. J. Med. 31:2000;247-261
20. Andersen T.I., Heimdal K.R., Skerede M., Tveit K., Berg K., Borresen A.L. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum. Genet. 94:1994;665-670
21. Lehrer S., Sanchez M., Song H.K., Dalton J., Levine E., Savoretti P., et al. Oestrogen receptor B-region polymorphisms and spontaneous abortion in women with breast cancer. Lancet. 335:1990;622-624
22. Kobayashi S., Inoue S., Hosoi T., Ouchi Y., Shiraki M., Orimo H. Association of bone mineral density with polymorphisms of the estrogen receptor gene. J. Bone Miner. Res. 11:1996;306-311
23. Salmen T., Heikkinen A.M., Mahonen A., Kroger H., Komulainen M., Saarikoski S., et al. The protective effect of hormone replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women. J. Bone Miner. Res. 15:2000;2479-2486
24. Deng H.W., Li J., Li J.L., Dowd R., Davies K.M., Johnson M., et al. Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J. Clin. Endocrinol. Metab. 85:2000;2748-2751
25. Lehrer S., Rabin J., Kalir T., Schachter B.S. Estrogen receptor variant and hypertension. Hypertension. 21:1993;439-441
26. Matsubara Y., Murata M., Kawano K., Zama T., Aoki N., Yoshino M., et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler. Thromb. Vasc. Biol. 17:1997;3006-3012